{"url_path":"/sec/hims/8-k/2026-06-15/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1773751/0001773751-26-000096-index.html","accession_number":"0001773751-26-000096","cik":"0001773751","ticker":"HIMS","issuer_name":"Hims & Hers Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1773751/0001773751-26-000096-index.html","primary_entity_key":"0001773751","primary_entity_name":"Hims & Hers Health, Inc."},"word_count":405,"has_tables":true,"body_markdown":"Item 5.07. Submission of Matters to a Vote of Security Holders.\n\n(a)(b) On June 11, 2026, Hims & Hers Health, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 28, 2026.\n\nOnly stockholders of record as of the close of business on April 15, 2026, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 222,525,754 shares of Company’s Class A common stock (“Class A Common Stock”) and 8,377,623 shares of the Company’s Class V common stock (“Class V Common Stock”) were outstanding and entitled to vote at the Annual Meeting. In deciding all matters at the Annual Meeting, the holders of our Class A Common Stock had the right to one vote for each share of Class A Common Stock they held as of the record date and the holders of our Class V Common Stock had the right to 175 votes for each share of Class V Common Stock they held as of the record date. The holders of our Class A Common Stock and Class V Common Stock voted as a single class on all matters presented at the Annual Meeting.\n\nThe tabulation of the stockholders’ votes on each proposal brought before the Annual Meeting is as follows:\n\nProposal 1: The election of nine directors to serve as directors until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified:\n\nNameForWithheldBroker Non-Votes\n\nAndrew Dudum1,504,939,83013,028,64274,228,233\n\nKofi Amoo-Gottfried1,517,440,666527,80674,228,233\n\nDeborah Autor1,516,370,2691,598,20374,228,233\n\nDelos Cosgrove, M.D.1,516,949,0851,019,38774,228,233\n\nAnja Manuel1,516,973,593994,87974,228,233\n\nChristopher Payne1,508,808,3099,160,16374,228,233\n\nAndrea Perez1,516,871,9861,096,48674,228,233\n\nKare Schultz1,516,971,244997,22874,228,233\n\nDavid Wells1,501,758,39316,210,07974,228,233\n\nProposal 2: The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026:\n\nForAgainstAbstentions\n\n1,591,246,881516,386433,438\n\nAs a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.\n\nProposal 3: Advisory approval of the Company’s executive compensation:\n\nForAgainstAbstentionsBroker Non-Votes\n\n1,506,477,17111,181,420309,88174,228,233\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nHIMS & HERS HEALTH, INC.\n\nDate: June 15, 2026By:/s/ Andrew Dudum\n\nAndrew Dudum\n\nChief Executive Officer"}